<DOC>
	<DOCNO>NCT02298920</DOCNO>
	<brief_summary>This study investigate metabolic fate route excretion 14CAZD0914 six male healthy volunteer .</brief_summary>
	<brief_title>AZD0914 Phase 1 ADME Study Healthy Volunteers</brief_title>
	<detailed_description>This open-label , single dose study 6 healthy male subject age 18 55 year . Each subject admit clinical pharmacology unit day prior dose Check ( Day -1 ) remain clinical pharmacology unit least target Day 8 ( 168 hour post-dose ) . All subject receive 3000 mg AZD0914 incorporate 18.5 MBq ( 500 Ci ) [ 14C ] administer single oral dose follow least 8 hour fast food . Subjects water . For specific food water restriction . This study investigate metabolic fate route excretion AZD0914 .</detailed_description>
	<criteria>1 . Healthy male subject 18 55 year age , inclusive , time consent suitable vein cannulation repeat venipuncture ; 2 . Subjects must able understand willing comply study procedure , restriction , requirement ; 3 . Within body mass index ( BMI ) range 19 30 kg/m2 , inclusive , screen ; 4 . Nonsmokers past 6 month ; 5 . In good health , determine clinically significant finding medical history , physical examination , 12lead ECG , vital sign judge Investigator ; 1 . Significant history clinical manifestation metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , neurological , psychiatric disease disorder , opinion Investigator , may either put subject risk participation study , interfere absorption , distribution , metabolism excretion drug , influence result subject 's ability participate study ; 2 . Any clinically significant abnormality rhythm , conduction , morphology rest ECG clinically significant abnormality 12lead ECG consider Investigator may interfere interpretation QT interval correct heart rate ( QTc ) change ; 3 . Any clinically significant abnormality clinical chemistry , hematology , UA result judge Investigator ; 4 . Abnormal vital sign , 10 minute supine rest , confirm repeat , define follow : systolic blood pressure &lt; 90 mmHg &gt; 140 mmHg ; diastolic blood pressure &lt; 50 mmHg &gt; 90 mmHg ; heart rate &lt; 40 &gt; 100 beat per minute ; 5 . Any clinically significant illness , medical/surgical procedure , trauma within 4 week first administration IP ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>